Panzyga Voluntary Withdrawal of One Lot
October 28, 2026
On Oct. 15, 2026, Octapharma USA, Inc. initiated a voluntary market withdrawal of one lot of Panzyga® (immune globulin intravenous, human-ifas) 10% liquid preparation.